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Abstract: The tetracycline repressor/operator system was adapted for use in Leishmania donovani. In 
order to investigate the possible importance and function of open reading frame F (ORFF) in 
Leishmania donovani strain AG83 that has a single copy of ORFF in the LD1 locus on chromosome 
35, we have attempted to generate tetracycline regulatable single allele mutants of ORFF. Leishmania 
cells expressing the tetracycline repressor were transfected with tetracycline inducible vector 
expressing ORFF gene and having hygromycin as the selectable marker. The first endogenous 
genomic copy of ORFF was knocked out by homologous replacement with an inducible copy. Single 
ORFF gene disruption having an inducible copy of ORFF did not affect the growth of the parasites. 
This study, even though not conclusive, shows the possibility of generating functional tetracycline 
regulatable single knock out mutants of Leishmania donovani. The present study also demonstrates 
that ORFF gene might be an important gene and may be involved in various functions like attachment 
of Leishmania to the macrophages. 
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INTRODUCTION 
 
Leishmania are protozoan parasites of the order 
Kinetoplastida that cause a variety of diseases in 
humans, from dermal lesions to visceral infections and 
are widespread in the tropics and subtropics. Current 
options for disease control and treatment are limiting 
The Leishmania genome project has identified new 
genes at a rapid rate. The 32.8-megabase haploid 
genome of Leishmania major (Friedlin strain) is 
published. By sequence homology, the products of 
many of these genes are predicted to participate in a 
variety of physiological activities and regulatory 
processes. However, the functions of a substantial 
fraction of these protein-coding genes are unknown. 
Unlike conventional gene replacement strategy, an 
inducible system that provides stringent regulation of 
gene expression in Leishmania offers great advantage 
for studying gene functions, particularly for essential 
genes and those encoding toxic products[1]. 
The tetracycline repressor/operator system has 
been used to regulate transcription in yeast, plants and 
eukaryotes[2-4]. There is as yet no reproducible evidence 
of a bonafide pol II promoter in Trypanosomatids[5,6]. 
Nevertheless studies have shown that the rRNA 
promoter is capable of directing efficient expression of 
a protein-coding gene by RNA polymerase I in these 
organisms[7-11]. Tetracycline inducible expression 
system employing a polI-like promoter has been used 
successfully in Trypanosoma. brucei, which allowed 
the precise control of the expression of introduced 
genes through a range of four orders of magnitude. The 
rRNA promoter from Leishmania donovani is well 
characterized [10]. Yan et al[1] have adapted an inducible 
promoter system that allows expression of protein-
coding genes to be regulated by a tetracycline 
responsive rRNA promoter in L. donovani. In this 
system, the tetracycline-responsive repressor (TETR) 
binds to the tetracycline-responsive operator (TetO) 
close to the transcription initiation site (TIS) and 
prevents transcription[12]. Transcription is induced by 
addition of tetracycline, which binds to the repressor, 
causing it to dissociate from the operator, thereby 
allowing transcription to proceed.  
A second generation tetracycline-responsive 
repressor-operator system has been generated earlier[6]. 
In the second-generation system, the selection marker 
(HYG) and the test gene (LUC) are placed on opposite 
DNA strands and are driven by different promoters[6]. 
In this system, expression of reporter luciferase gene 
(LUC) is driven by the inducible Leishmania ribosomal 
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RNA promoter on the DNA strand opposite to a 
hygromycin resistance gene (HYG) whose expression 
is driven by the endogenous pol I promoter  (rDNA 
locus) or the endogenous pol II promoter  (LD1 locus). 
We have attempted to generate tetracycline regulatable 
mutants of ORFF gene in Leishmania donovani using 
this second generation tetracycline-responsive 
repressor-operator system. 
The multigene LD1 locus is present on 
chromosome 35 in all Leishmania isolates examined[13-
18]. This sequence is amplified in approximately 15% of 
all Leishmania strains examined[18]. This amplification 
occurs in the absence of an intentional drug selection, 
suggesting that it has an important role. The gene 
ORFF from the LD1 locus encodes ~32 kDa protein 
which is localized in the nucleus[13]. This gene is 
universally amplified in all strains of Leishmania 
showing LD1 amplification, suggesting that it may 
provide a selective advantage for the parasite survival. 
Recombinant ORFF protein (rORFF) has been found to 
be a differential diagnostic and a promising vaccine 
candidate[17,19-23]. The protein product of this gene does 
not have sequence homology to any known protein in 
the database indicating that it may be a Leishmania 
specific gene product.  
In order to study the possible importance and 
function of ORFF gene, we have attempted to generate 
tetracycline regulatable mutants of ORFF in 
Leishmania donovani strain AG83 that has a single 
copy of ORFF in the LD1 locus on chromosome 35. 
Leishmania cells expressing the tetracycline repressor 
were transfected with tetracycline inducible vector 
expressing ORFF gene and having hygromycin as the 
selectable marker. These genetically engineered ORFF 
mutants of Leishmania were characterized for the 
scorable changes in their phenotype. 
 
MATERIALS AND METHODS 
 
Parasite cell culture: All parasite cell lines used in 
this study were derived from an Indian isolate of L. 
donovani AG83 (MHOM/IN/1983/AG83). 
Promastigotes were grown at 22ºC in M199 medium 
(Sigma) with 10% fetal calf serum (FCS) (GIBCO, 
BRL). 
 
Plasmid constructs: Plasmid constructs that were used 
for transfections are shown in Figure 1. The first 
construct pTupactet[1,6] was used to insert the TETR 
gene into the α-tubulin locus of L. donovani (Figure 
1A). pTupactet contains the puromycin N-acetyl 
transferase (PAC) gene flanked by the 5’ and 3’ 
intergenic regions from the L. major  
  
  
Fig. 1: Steps involved in the creation of tetracycline 
regulatable knockout of ORFF and the 
plasmid constructs used in targeted gene 
replacement experiments.  A: Construct 
pTupactet used to introduce TetR into the 
tubulin locus. B: Construct pTcF used to 
replace first allele of ORFF with tetracycline 
regulatable allele of ORFF.  
 
dihydrofolate reductase/thymidilate synthetase (DHFR-
TS) gene[24] and the Tn10-encoded TETR gene[4] 
(Figure 1A). The 5’ and 3’ DHFR-TS intergenic 
regions provide the splice leader sequence and the poly 
A+ tail for the expression of selectable markers.    
Generation of pTcF.  Plasmid pFHLTG that had the 
LUC gene under the control of a tetracycline-inducible 
PRRNA, downstream and on the opposite strand of HYG 
was used in the present study to generate the construct 
pTcF[1,6] (Figure 1B). ORFG also known as BT1 has 
been mentioned in Figure 1B as BT1. 
Three sub-cloning steps were involved in the 
construction of pTcF from pFHLTG. 
1. F-G intergenic region was amplified from AG83 
genomic DNA by PCR using primers 5’ApaFG - 
ACGTGGGCCCTAAGCGCCTCGCCTATACC and 
3’KHdFG –  
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Fig. 2: Schematics of the ORFF genomic region 
before and after the targeted deletions of 
ORFF gene. The various probes giving the 
expected band size is given in brackets. A: 
schematic representation of LD1 genomic 
locus. B: ClaI and ApaI fragment in wild type 
AG83. C: Changes in ClaI and ApaI 
restriction-fragment size following HYG 
construct integration (pTcF) are indicated. The 
size of the ClaI and NotI restriction- fragment 
obtained is also shown.  
 
ACGTGGTACCAAGCTTAGTCGCATCAGCCCAT
TG. The 432-bp PCR product obtained was purified, 
digested with ApaI and KpnI and cloned into ApaI and 
KpnI digested plasmid pFHLTG. The clone pFHLT-FG 
of size 10.76 kb was used for the next sub-cloning step. 
2. E-F intergenic region was amplified from AG83 
genomic DNA by PCR using primers   5’BstEF-
CTGCAGAACCAATGCATTGGCGTGCCTGTGTG
CGTAAG and 3’AscEF - 
ACTGGCGCGCCTACAGCAGGAGCTACATAAAC
G. The 340-bp PCR product obtained was purified, 
digested with BstXI and AscI and cloned into BstXI 
and AscI digested plasmid pFHLT-FG. The clone pEF-
HLT-FG (10.2 kb) was used for the third sub-cloning 
step. 
3. ORFF was amplified from AG83 genomic DNA by 
PCR using primers 5’BamF –  
 
 
 
Fig. 3:  Genomic Southern blot analysis of 
AG83/tetR clones using TetR probe (647 
bp). Genomic DNA was isolated from 
AG83/tetR clones and was digested with 
HindIII. The DNA was size fractionated on 
1% agarose gel and blotted to nylon 
membrane. The filters were hybridized with 
32P-labeled TetR probe. Filters were washed 
and exposed overnight to X-ray film. Lanes 
1, 2, 3 and 4 shows HindIII digested clones 
1, 2, 3 and 4 respectively. Molecular size 
markers (GIBCO/BRL) are shown to the 
right. 
 
CAGGGATCCGCGGCTATGCTTCCTGTGAG and 
3’AvrF-
ACGTCCTAGGTTAACAGACGCCACCACG. The 
1.1 kb PCR product obtained was purified, digested 
with BamHI and AvrII and cloned into BglII and AvrII 
digested plasmid pEF-HLT-FG. The identity of the 
final construct pTcF (9.2 kb) (Figure 1B) was done by 
sequencing and restriction analysis. 
The construct pTcF was linearized by digestion with 
respective restriction enzymes and purified by 
electrophoresis on low melting agarose before 
transfection. Mainly two steps were involved in the 
creation of tetracycline regulatable single knockouts of 
ORFF. As a first step, the tet repressor (TetR) was 
introduced into the tubulin locus (selectable marker 
was puromycin) (Figure 1A). 
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Fig. 4: Genomic Southern blot analysis of 
AG83/TetR/∆F,rPF clones using 
hygromycin probe (1048-bp). Genomic 
DNA was isolated from AG83/TetR/∆F,rPF 
clones and was digested with ClaI and NotI.  
The DNA was size fractionated on 1% 
agarose gel and blotted to nylon membrane. 
The filters were hybridized with 32P-labeled 
HYG probe. Filters were washed and 
exposed overnight to X-ray film. Lanes 1, 2, 
3 and 4 shows ClaI and NotI digested 
clones 1, 2, 3 and 4 respectively. Lane 5 
shows the linearized pTcF plasmid (positive 
control). Molecular size markers 
(GIBCO/BRL) are shown to the right. 
 
The second step was to replace the first allele of ORFF 
with the tetracycline inducible allele of ORFF 
(selectable marker used was hygromycin) (Figure 1B). 
Figure 2 shows the schematics of the ORFF genomic 
region before and after the targeted single allele 
deletion of ORFF gene. pFHLTG construct was used to 
check for the functionality of Tetracycline repressor 
(TetR) introduced into tubulin locus of L.  donovani 
strain AG83 using transient luciferase assay[1]. 
 
DNA transfection: Methods of electroporation and 
plating of L. donovani have been described 
previously[25]. Briefly, 4 × 107 promastigotes of L. 
donovani in 0.4 ml electroporation buffer (21 mM 
HEPES, 137 mM NaCl, 5 mM KCl, 0.7 mM NaH2PO4, 
6 mM glucose, pH 7.4) were transfected with 5 µg of 
DNA by electroporation at 480 V, 500 µF, 13 Ω (BTX 
Electro Cell Manipulator 600). Cells were cultured for 
~ 24 h in M199 media containing 10% FCS before 
spreading on plates containing 0.7%  Seaplaque GTG 
agarose (FMC Bioproducts) in M199 media (with 10% 
FCS) with puromycin (45 µM) or hygromycin (25 
µg/ml) to select for single colonies. Wild type AG83 
was maintained in M199 (10% FCS), ORFF single 
knockout (AG83/tetR/∆F,rPF) was maintained in 
M199 (10% FCS) with hygromycin (25 µg/ml) and 
tetracycline (10 µg/ml). 
 
Luciferase assay: Approximately 105 or 106 cells were 
lysed and assayed for luciferase activity using a 
Monolight luminometer (Analytic Luminescence 
Laboratory) following manufacturer’s instructions. The 
luciferase activities were measured for 10 s. 
Experiments were repeated thrice and the data 
presented are representative. 
 
Nucleic acid isolation and hybridization analysis: 
Genomic DNA was extracted from Leishmania using 
earlier reported method.[26]. Late log-phase 
promastigotes were collected by centrifugation, washed 
in 1 x phosphate buffered saline (PBS), resuspended in 
EA solution (0.01 M Tris, pH 8.0, 0.25 M NaCl, 
0.005% NP-40) and incubated for 5 min at room 
temperature. Lysates were spun at 13,000 x g for 15 
min and the pellets resuspended in EB solution (0.01 M 
Tris, pH 8.0, 0.01M EDTA, 0.5% SDS, 50 µg/ml 
proteinase K) and incubated on ice for 5 min. The 
DNA was extracted sequentially with equal volumes of 
phenol:chloroform:isoamylalcohol (25:24:1) and 
chloroform:isoamyl alcohol (24:1), then precipitated at 
–20ºC with 0.3 M sodium acetate and 1 volume of 
isopropanol. The DNA pellet was collected by 
centrifugation and resuspended in TE (10 mM Tris, pH 
8.0, 1 mM EDTA). 10 µg of DNA was digested with 
appropriate restriction enzymes and separated by 1% 
agarose gel electrophoresis, stained with ethidium 
bromide, and transferred to nylon membranes as 
described previously[15]. 
Total RNA was isolated from Leishmania using Tri-
reagent (Sigma) according to manufacturer’s  
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Fig. 5: Northern blot analysis of AG83/TetR/∆F,rPF 
(SKO) using ORFF specific probe in the 
absence and presence of tetracycline. Total 
RNA was isolated from wild type, 
AG83/TetR/∆F, rPF cells grown in the 
presence and absence of tetracycline. 10 µg of 
total RNA was run on a 1% formaldehyde gel 
and transferred to nylon membrane. The filters 
were hybridized with 32P-labeled ORFF 
probe. A: Ethidium bromide stained 
formaldehyde gel. B: Northern blot probed 
with ORFF probe. Lane 1: total RNA from 
AG83 (wild type cells). Lane 2: RNA isolated 
from SKO cells grown in the absence of 
tetracycline. Lane 3: total RNA isolated from 
single knockout cells grown in the presence of 
tetracycline. All the 3 lanes show the presence 
of the wild type copy of ORFF (1.1 kb) in the 
Northern blot. The SKO cells in the presence 
of tetracycline showed the presence of 3.3 kb 
inducible copy of ORFF besides 1.1 kb wild 
type allele. 
 
instructions. Approximately 10 µg of total RNA was 
separated on MOPS/formaldehyde agarose gel and 
transferred to nylon membrane and cross-linked to the 
filters with a Stratagene UV-cross linker (Stratagene) 
according to manufacturer’s instruction.  
Blots were hybridized with radiolabeled probes 
prepared by Prime-a-Gene random prime synthesis 
with Klenow DNA polymerase and α[32P]dCTP. The 
EK1 probe[27,18] corresponding to ORFF of LD1 locus 
was used for hybridization. Hybridization was carried 
out for 16-18 h at 42°C. The TetR probe (647 bp) was 
obtained by digesting pTupactet with BamH1 and SpeI. 
Hygromycin probe (1048 bp) was obtained from pTcF 
by digesting the plasmid with SpeI and BamHI. The 
probe specific for ORFF gene was obtained by the 
restriction digestion of pTcF using enzymes KpnI and 
AvrII.  
 
Growth studies: Growth profile of AG83, single 
ORFF targeted mutants of AG83 in the presence and 
absence of tetracycline  was studied by inoculating 
stationary phase cells in M199 (10% FCS) at a density 
of ~2 x 106 cells/ml. Cells were counted at 24 h 
intervals using hemocytometer. 
 
In vitro macrophage infection: J774.A1 murine 
macrophage cells were plated in 35 mm tissue culture 
dishes at a density of 1 x 105 per dish. In vitro infection 
of J774A.1 macrophages was done with 1 x 106 labeled 
promastigotes of AG83 and ORFF single allele 
deletion mutants in the presence and absence of 
tetracycline. Parasites were labeled by resuspending 
them at a density of 1 × 107 cells/2 ml M199 medium 
having 8 µCi/ml [3H]-Thymidine (specific activity = 
89.4 Ci/mmol, New England Nuclear) and incubated 
for 3 h at 22°C. After the incubation, monolayers were 
washed twice with 1 ml PBS to remove unbound 
parasites and placed on ice to loosen adherent cells 
from the plates. Samples were processed for 
scintillation counting by adding 500 µl of 0.5% Triton 
X-100 per dish and transferring the solution onto GF/C 
filters. Filters were then dried in the oven, soaked in 
scintillation fluid (5 ml) and counting was done using a 
Packard Tri-Carb liquid scintillation counter. 
 
RESULTS 
 
Introduction of tetracycline repressor (TetR) into 
tubulin locus of L.  donovani: L. donovani (AG83) 
cells which have a single copy of ORFF  
 
Table 1: Transient luciferase assay to estimate 
the regulation of TetR in the tubulin 
locus using tetracyline as the inducer 
 
4 × 107 cells (4 clones of L. donovani strain AG83 
positive for TetR integration into tubulin locus and 
L donovani cell line 4.1.3) were electroporated 
using 5 µg of pFHLTG (which has a Luciferase 
gene driven by a regulatable promoter). After 
electroporation, half of the cells were grown in the 
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presence of tetracycline and the other half in the 
absence of tetracycline. Luciferase assay was done 
on the next day. As a control, L donovani cell line 
413, expressing tetR from α-tubulin locus of LSB-
51.1 was also used. The Luciferase activities are 
given as average relative light units (RLU) from 
duplicate samples. 
 
gene at the LD1 locus on chromosome 35 were used 
for these studies. Plasmid pTupactet, linearized using 
KpnI and NotI. was electroporated into 4 × 107 L. 
donovani (AG83) cells. As a control, uncut plasmid 
(pTupactet) was also electroporated into L. donovani 
cells. Cells growing in the presence of puromycin were 
cloned on M199/10% FCS/puromycin/semisolid agar 
plates. 30 colonies were obtained using one microgram 
of linearized pTupactet. 22 colonies from this group 
were picked up and grown in 1ml of M199/10% 
FCS/puromycin (Group 1). Approximately 200 
colonies were obtained using  nonlinearized pTupactet. 
8 colonies from this group were picked up and grown 
in 1ml of M199/10% FCS /puromycin (Group 2). 
Slowly the culture was scaled up to 10 ml. Four clones 
from Group 1 and two clones from Group 2 were 
chosen for Southern analysis. Genomic DNA from the 
clonal transfectants was digested with HindIII and 
transferred to nylon membrane according to the 
protocol given in the materials and methods section. 
The blot was hybridized with the TetR probe (647-bp). 
Clones 1, 2, 3 and 4 (obtained by transfecting with 
linearized pTupactet) showed a 4.6-kb band upon 
hybridization with TetR probe (Figure 3, Lanes 1, 2, 3 
and 4). This is consistent with the integration of TetR 
into the tubulin locus. The genomic DNA from clones 
transfected with circular plasmid showed a 7.6-kb band 
indicating their existence as an episome within the 
Leishmanial cells (data not shown). Genomic DNA 
from non-transfected AG83 cells did not hybridize with 
the TetR probe (data not shown). Thus it was 
confirmed that TetR is integrated into the tubulin locus.   
 
Regulation of TetR in the tubulin locus using 
tetracyline as the inducer: In order to check whether 
TetR is functional in the genome of cell lines where it 
was integrated, transient luciferase assay was done. As 
a control, L donovani cell line 4.1.3, expressing TetR 
from α-tubulin locus of LSB-51.1[1] was also used. 4 × 
107 cells (4 clones of L. donovani strain AG83 positive 
for TetR integration into tubulin locus and L donovani 
cell line 4.1.3) were electroporated with pFHLTG 
construct (which has a Luciferase gene driven by a 
regulatable rRNA promoter) [6]. After electroporation, 
half of the cells were grown in the presence of 
tetracyclin and the other half in the absence of 
tetracycline. Luciferase assay was done on the next 
day. The results of the assay are given in Table 1. 
All the clones showed more than 10-fold regulation of 
luciferase activity in the presence of tetracycline 
(compared to the cell population where no tetracycline 
was added). Thus TetR was functional and could be 
regulated by tetracycline added externally to the media. 
The transformed AG83 clone (clone 2) expressing TetR 
in the tubulin locus was named as AG83/tetR and was 
used for the further studies. Henceforth, AG83/tetR 
cells are depicted as wild type in all the experiments. 
 
Replacement of one allele of ORFF with the 
tetracycline regulatable allele of ORFF to create 
AG83/tetR/∆F,rPF (SKO, Single knockout): First 
wild type allele of ORFF was knocked out using the 
construct pTcF. AG83/tetR cells were transfected with 
linearized pTcF (digested with BstXI and HindIII). The 
transfectants were plated on 
M199/10%/hygromycin/tetracycline plates. Four 
clones were obtained. Total genomic DNA from all the 
clones was digested with ClaI and NotI and analysed 
by Southern blot. As a positive control, linearized pTcF 
(9.2 kb) was also used. Figure 4 shows the 
corresponding Southern blot after  
 
 
Fig. 6: Growth rate analysis of wild type and single 
knockout clone of Leishmania. Growth profile 
of wild type, single knockout in the presence 
of tetracycline (SKO + tet) and single 
knockout clone in the absence of tetracycline 
(SKO-tet) was done by inoculating stationary 
phase cells in M199(10% FCS) at a density of 
2 × 106 cells/ml. Cells were counted at 24 h 
intervals using a hemocytometer. 
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Fig. 7: In vitro infection of J774A.1 macrophages was 
done with 1 x 106 labeled (3H-thymidine) 
promastigotes of AG83 and AG83/TetR/∆F,rPF 
(SKO) in the presence and absence of 
tetracycline. Parasites (107 cells/ 2 ml 
M199/10% FCS) were labeled with 8 µCi/ml 
[3H]-Thymidine and incubated for 3 h at 22°C. 
After the incubation, monolayers were washed 
twice with 1 ml PBS and layered with Triton X 
100 (1%) to lyse the macrophages. Samples 
were processed for scintillation counting by 
transferring the solution onto GF/C filters. 
Filters were then dried in the oven, soaked in 
scintillation fluid (5 ml) and counted. The results 
are given as percentage infectivity. The results 
shown here represent the mean of two 
experiments. 
 
hybridization with hygromycin probe. Lanes 1, 2, 3 and 
4 represent clones 1, 2, 3 and 4 respectively. Lane 5 
shows the linearized pTcF control. All the clones 
showed the expected band size of 4.1 kb on 
hybridization with hygromycin probe (Figure 4). One 
of the clones (clone 2, Lane 2) was named as 
AG83/tetR/ ∆F, rPF (SKO) and used for further 
studies. 
 
ORFF expression in AG83/tetR/∆F,rPF (SKO) in 
the presence and absence of tetracycline: In order to 
check the expression of ORFF in AG83/tetR/∆F,rPF in 
the presence and absence of tetracycline, 
AG83/tetR/∆F,rPF mutant was grown in the presence 
and in the absence of tetracycline. Total RNA was 
isolated from log phase culture of the clone. Northern 
analysis was done using ORFF specific DNA probe. 
The ORFF probe was obtained by the restriction 
digestion of pTcF using enzymes KpnI and AvrII. 
Figure 5A shows the ethidium bromide stained RNA 
gel. Lane 1 represents wild type (AG83), lane 2 shows 
SKO clone grown in the absence of tetracycline and 
lane 3 shows the same SKO clone grown in the 
presence of tetracycline. RNA isolated from wild type 
cells (Lane 1) and SKO grown in the absence (Lane 2) 
and presence of tetracycline (Lane 3) showed the 
expression of the wild type allele (1.1 kb) (Figure 5B). 
Apart from the wild type allele, the single knockout 
clone in the presence of tetracycline also showed the 
expression of the inducible allele of ORFF (3.3 kb), 
which was absent in the wild type and also SKO clone 
in the absence of tetracycline (Figure 5B).  
 
Growth rate analysis: The doubling time of wild type 
AG83 was 36 h and that of single knockout was 40 h in 
the presence of tetracycline. The single knockout 
mutants did not show any difference in the doubling 
time in the presence and absence of tetracycline 
(Figure 6).  
 
In vitro infectivity assay: In vitro infection of 
J774A.1 macrophages was done with 1 x 106 labeled 
promastigotes of AG83, and AG83/tetR/∆F,rPF in the 
presence and absence of tetracycline. Infectivity into 
macrophages reduced by almost 80% with single 
knockout clone in the absence of tetracycline compared 
to the wild type AG83 and AG83/tetR/∆F,rPF in the 
presence of tetracycline.  
 
DISCUSSION 
 
 The targeted gene deletion of ORFF gene 
from the LD1 locus of Leishmania donovani was 
accomplished by adapting the tetracycline responsive 
inducible promoter system in the ORFF genomic 
region. As the first step, the tetracycline repressor 
(TetR) was introduced into the tubulin locus of 
Leishmania donovani (AG83) to create AG83/tetR. 
The next step involved the cloning of ORFF gene 
under the control of tetracycline regulatable rRNA 
promoter in the reverse orientation compared to the 
transcription of the selectable marker gene (HYG). This 
construct was used to replace the first wild type allele 
of ORFF gene at the LD1 locus. 
Southern analysis of the single targeted mutants using 
ORFF specific probe showed that all the clones 
possessed the inducible copy of ORFF along with the 
wild type copy. We were successful in generating 
tetracycline regulatable single knock out mutants of 
ORFF in Leishmania donovani strain AG83.  
The functional study in the context of parasite’s growth 
carried out in the single knockouts in the presence of 
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tetracycline showed that the growth rate of the single 
targeted knockouts was not different from the wild type 
and the single targeted knockouts grown in the absence 
of tetracycline  
The in vitro infectivity studies have shown that the 
infectivity, more precisely the attachment of the 
recombinant parasites to the macrophages was 
considerably reduced (80% in the absence of 
tetracycline) when compared to the wild type.  
This study, even though not conclusive, shows the 
possibility of generating functional tetracycline 
regulatable single knock out mutants of Leishmania 
donovani. The present study also demonstrates that 
ORFF gene might be an important gene for the survival 
of the parasite and it may be involved in various 
functions like attachment of the macrophages to 
Leishmania.  
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